Oxford BioMedica (LSE:OXB) Total Assets : £252.34 Mil (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Oxford BioMedica Total Assets?

Oxford BioMedica's Total Assets for the quarter that ended in Dec. 2023 was £252.34 Mil.

Warning Sign:

If a company builds assets at 20% a year, faster than its revenue growth rate of 5.3% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Oxford BioMedica's average Total Assets Growth Rate was -53.40% per year. During the past 3 years, the average Total Assets Growth Rate was 2.80% per year. During the past 5 years, the average Total Assets Growth Rate was 20.00% per year. During the past 10 years, the average Total Assets Growth Rate was 31.80% per year.

During the past 13 years, Oxford BioMedica's highest 3-Year average Total Assets Growth Rate was 60.10%. The lowest was -17.90%. And the median was 23.60%.

Total Assets is connected with ROA %. Oxford BioMedica's annualized ROA % for the quarter that ended in Dec. 2023 was -67.05%. Total Assets is also linked to Revenue through Asset Turnover. Oxford BioMedica's Asset Turnover for the quarter that ended in Dec. 2023 was 0.14.

Oxford BioMedica Total Assets Historical Data

The historical data trend for Oxford BioMedica's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioMedica Total Assets Chart

Oxford BioMedica Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

122.93

183.93

237.23

460.18

252.34

Oxford BioMedica Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Assets	Get a 7-Day Free Trial															237.23	466.70	460.18	401.07	252.34

Oxford BioMedica Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Oxford BioMedica's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	77.834	+	174.508
	=	252.34

Oxford BioMedica's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	77.834	+	174.508
	=	252.34

Oxford BioMedica (LSE:OXB) Total Assets Explanation

Total Assets is connected with ROA %.

Oxford BioMedica's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-219.068	/	( (401.065	+	252.342)	/ 2 )
	=	-219.068	/	326.7035
	=	-67.05 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Oxford BioMedica's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	46.478	/	( (401.065	+	252.342)	/ 2 )
=	46.478	/	326.7035
=	0.14

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Oxford BioMedica Total Assets Related Terms

Thank you for viewing the detailed overview of Oxford BioMedica's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioMedica (LSE:OXB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioMedica PLC (LSE:OXB) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

OXBDF:USA OXBl:UK OXO:Germany

Address

Windrush Court, Transport Way, Oxford, GBR, OX4 6LT

Website

https://www.oxb.com

Oxford BioMedica PLC is a player in the healthcare market in the United Kingdom. As a biopharmaceutical company, it focuses on the field of immunotherapy by managing a platform of technologies for designing gene-based medicines. The company's operating segments include the Platform segment consists of the revenue-generating bioprocessing and process development activities undertaken for third parties. Its Product segment consists of the clinical and preclinical development of in vivo and ex vivo gene and cell therapy products. The company derives the maximum revenue from the Platform segment. Its Platform includes LentiVector, LentiStable, TRiPSystem, SecNuc, Analytics, and others. Geographically, it generates the majority of its revenue from Europe.

Oxford BioMedica (LSE:OXB) Headlines

No Headlines